SEK 105.2
Key Takeaways
Risk factor
Low price volatility
Profitability factor
Very strong margins and returns
About
BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair value on
Target Price
The average target price of BIOG-B.ST is 130 and suggests 24% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in
